Journal of craniovertebral junction & spine · 2025
National trends in post-operative complications for anterior cervical discectomy and fusion versus cervical disc arthroplasty from 2012 to 2022.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Tse Emily L, Luo Yijie, Fritz Amalvin, Hoang Ryan, Le Ryan, Lee Joshua, Ross Noah Makaio, Morrissey Joe, Park Don Young, Hashmi Sohaib, Wu Hao-Hua, Bhatia Nitin, Lee Yu-Po
Аннотация
INTRODUCTION: Anterior cervical discectomy and fusion (ACDF) and cervical disc arthroplasty (CDA) are common treatments for cervical radiculopathy and myelopathy. While ACDF remains the gold standard, CDA is gaining popularity due to the benefit of motion preservation. However, national trends in outcomes between these procedures remain unclear.
METHODS: A retrospective analysis was performed using the American College of Surgeons National Surgical Quality Improvement Program database to identify patients aged >18 who underwent ACDF or CDA between 2012 and 2022, using CPT codes 22551 and 22856. Annual rates of demographics, comorbidities, and 30-day complications were analyzed. Univariate analysis evaluated outcomes including readmission, reoperation, and length of stay (LOS).
RESULTS: We identified 93,989 ACDF and 8708 CDA patients. From 2012 to 2022, the proportion of ACDF cases declined from 96.3% to 90.2%, while CDA cases increased from 3.7% to 9.9%. ACDF patients were older (55.7 vs. 46.8 years) and had higher body mass index (30.6 vs. 29.6) (P < 0.001). Diabetes increased in both cohorts (ACDF: 15.3%-20.7%; CDA: 5.9%-11.3%), as did hypertension (ACDF: +8.7%; CDA: +5.4%) (P < 0.001). Steroid use (+2.2%, P < 0.001) and chronic obstructive pulmonary disease (+1.0%, P = 0.021) rose in ACDF only. LOS decreased in ACDF (1.94-1.76 days, P < 0.001) but rose in CDA (1.10-1.15 days, P = 0.023). Readmissions increased in both (ACDF: 2.9%-3.25%; CDA: 0.74%-1.01%, P < 0.001).
CONCLUSION: CDA continues to show favorable short-term outcomes compared to ACDF but remains less utilized overall. These trends may guide surgical planning and patient counseling in cervical spine care.
METHODS: A retrospective analysis was performed using the American College of Surgeons National Surgical Quality Improvement Program database to identify patients aged >18 who underwent ACDF or CDA between 2012 and 2022, using CPT codes 22551 and 22856. Annual rates of demographics, comorbidities, and 30-day complications were analyzed. Univariate analysis evaluated outcomes including readmission, reoperation, and length of stay (LOS).
RESULTS: We identified 93,989 ACDF and 8708 CDA patients. From 2012 to 2022, the proportion of ACDF cases declined from 96.3% to 90.2%, while CDA cases increased from 3.7% to 9.9%. ACDF patients were older (55.7 vs. 46.8 years) and had higher body mass index (30.6 vs. 29.6) (P < 0.001). Diabetes increased in both cohorts (ACDF: 15.3%-20.7%; CDA: 5.9%-11.3%), as did hypertension (ACDF: +8.7%; CDA: +5.4%) (P < 0.001). Steroid use (+2.2%, P < 0.001) and chronic obstructive pulmonary disease (+1.0%, P = 0.021) rose in ACDF only. LOS decreased in ACDF (1.94-1.76 days, P < 0.001) but rose in CDA (1.10-1.15 days, P = 0.023). Readmissions increased in both (ACDF: 2.9%-3.25%; CDA: 0.74%-1.01%, P < 0.001).
CONCLUSION: CDA continues to show favorable short-term outcomes compared to ACDF but remains less utilized overall. These trends may guide surgical planning and patient counseling in cervical spine care.